Evidence map›Paper›PMID 38146468›Full record

ArticleInternational journal of nanomedicine2023

Key Fabrications of Chitosan Nanoparticles for Effective Drug Delivery Using Flow Chemistry Reactors.

Kampanart Huanbutta, Pornsak Sriamornsak, Kittipat Suwanpitak, Nattapat Klinchuen, Thanapat Deebugkum, Vasanchai Teppitak, Tanikan Sangnim

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kampanart HuanbuttaDepartment of Manufacturing Pharmacy, College of Pharmacy, Rangsit University, Pathum Thani, 12000, Thailand.
Pornsak SriamornsakDepartment of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 73000, Thailand.
Kittipat SuwanpitakDepartment of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand.
Nattapat KlinchuenDepartment of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand.
Thanapat DeebugkumDepartment of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand.
Vasanchai TeppitakDepartment of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand.
Tanikan SangnimDepartment of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand.ORCID 0000-0002-9332-384X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chitosan nanoparticles have garnered considerable interest in the field of drug delivery owing to their distinctive properties, including biocompatibility, biodegradability, low toxicity, and ability to encapsulate a wide range of drugs. However, the conventional methods (eg, the drop method) for synthesizing chitosan nanoparticles often face limitations in regard to controlling the particle size, morphology, and scalability, hindering their extensive application in drug delivery systems. To overcome these challenges, this study explores using a novel flow chemistry reactor design for fabricating clindamycin-loaded chitosan nanoparticles. Methods: By varying two critical operating parameters of flow chemistry, namely, the flow rate ratio and total flow rate, the impact of these parameters on the properties of chitosan nanoparticles is investigated using a central composite experimental design. Results: The optimized conditions for nanoparticle preparation yielded remarkable results, with chitosan nanoparticles exhibiting a small size of 371.60 nm and an extremely low polydispersity index of 0.042. Furthermore, using novel design flow chemistry reactor, the productivity of chitosan nanoparticles was estimated to be 25,402.17 mg/min, which was ~12.71 times higher than that obtained via batch synthesis. Conclusion: The findings of this study indicate that the use of novel design flow chemistry reactor is promising for synthesizing clindamycin-loaded chitosan nanoparticles and other polymeric nanoparticles intended for drug delivery applications. This is primarily attributed to their ability to produce nanoparticles with a considerably reduced particle size distribution and smaller overall size. The demonstrated high productivity of this technique suggests the potential for industrial-scale nanoparticle manufacturing.

Indexed as

ChitosanNanoparticlesClindamycinDrug CarriersDrug Delivery SystemsParticle SizeChitosanClindamycinDrug Carrierschitosan nanoparticlescontinuous manufacturingdrug deliveryflow chemistrysodium tripolyphosphate

Identifiers

PMID38146468
PMCPMC10749571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.